According to newly published research the marijuana compound cannabidiol “shows potential as an abortive agent for treating migraine attacks and headache-related conditions such as spontaneous pain and anxiety”.
The study is published in the peer-reviewed journal Pain, and it’s conducted by researchers at Florida Atlantic University, the Medical University of Lublin in Poland, and the Universities of Ferrara and Padova, both in Italy.
“Migraine is a disabling disorder characterized by recurrent headaches, accompanied by abnormal sensory sensitivity and anxiety”, notes the study’s researchers. “Despite extensive historical use of cannabis in headache disorders, there is limited research on the nonpsychoactive cannabidiol (CBD) for migraine and there is no scientific evidence to prove that CBD is an effective treatment.”
Continue reading